Parphezein en es it fr

Parphezein Brand names, Parphezein Analogs

Parphezein Brand Names Mixture

  • No information avaliable

Parphezein Chemical_Formula


Parphezein RX_link

No information avaliable

Parphezein fda sheet

Parphezein msds (material safety sheet)

Parphezein Synthesis Reference

No information avaliable

Parphezein Molecular Weight

312.473 g/mol

Parphezein Melting Point

64.5 oC

Parphezein H2O Solubility

0.693 mg/L

Parphezein State


Parphezein LogP


Parphezein Dosage Forms

Tablet (10 mg); Tablet (scored, 50 mg)

Parphezein Indication

For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.

Parphezein Pharmacology

Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.

Parphezein Absorption

Well-absorbed from the gastrointestinal tract.

Parphezein side effects and Toxicity

Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.

Parphezein Patient Information

Parphezein Organisms Affected

Humans and other mammals